Advertisment

Intas Pharma

USFDA pulls up Intas Pharma for manufacturing lapses at Ahmedabad plant

The US health regulator has pulled up Intas Pharmaceuticals for manufacturing lapses, including violation of current good manufacturing practice (CGMP) regulat...

USFDA issues warning letter to Intas Pharma for Sanand plant

Advertisment

Advertisment

Latest Stories

Authors

Advertisment

Subscribe